SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-17-002325
Filing Date
2017-08-08
Accepted
2017-08-08 16:09:55
Documents
57
Period of Report
2017-08-08

Document Format Files

Seq Description Document Type Size
1 6-K zk1720375.htm 6-K 15193
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 52486
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 516244
10 image0.jpg GRAPHIC 86413
11 image00001.jpg GRAPHIC 1815
  Complete submission text file 0001178913-17-002325.txt   3230071

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fomx-20170630.xml EX-101.INS 592764
5 XBRL TAXONOMY EXTENSION SCHEMA fomx-20170630.xsd EX-101.SCH 32480
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20170630_cal.xml EX-101.CAL 57897
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20170630_def.xml EX-101.DEF 121636
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fomx-20170630_lab.xml EX-101.LAB 253156
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20170630_pre.xml EX-101.PRE 208251
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36621 | Film No.: 171014809
SIC: 2833 Medicinal Chemicals & Botanical Products